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analyzed, the inferences drawn will be biased. Hence we planned to study the QoL and its determinants in psoriasis. mEthodology This was a cross-sectional, hospital-based study conducted on outpatients from the dermatology department in a tertiary care teaching hospital. All consecutive adult patients (18-60 years) who gave their written informed consent were screened for psoriasis clinically by two dermatologists. Patients were excluded if they had a mental illness before the onset of psoriasis.
The following rating scales were administered:
The simplified psoriasis index (SPI) is a practical tool for assessing psoriasis in the clinical setting. [7] It provides a simple yet holistic summary of psoriasis severity. Its three components included separate indicators of current severity, psychosocial impact, and historical course. The tool has demonstrated good validity and intra-and inter-rater reliability. [7] For this study, the first component, i.e., current severity (SPI-s), was used to measure the clinical severity of psoriasis.
The psoriasis life stress inventory (PLSI) is a 15-item questionnaire that provides a measure of the daily hassles and stressors of everyday life, specifically experienced by patients with psoriasis with good reliability and validity. [8] Each scenario is rated on 4-point Likert scale from 0 (not experienced or not at all stressful) to 3 (a great deal stressful) based on how stressful each situation is perceived. A cutoff score of 10 distinguishes between high-and low-stress reactors.
Psoriasis-specific stigma was assessed using the 6-item stigmatization scale. Stigmatizing experiences are scored on a 3-point Likert scale with higher scores indicating greater stigma. The scale has shown to be a valid and reliable tool to measure in stigmatization in psoriasis. [9] Psychiatric morbidity was assessed using the 12-item general health questionnaire (GHQ-12). It has demonstrated excellent reliability and validity across various settings and populations, correlating with both well-being and distress. [10] Scoring was done using a 3-point Likert scale from 0 to 3, with scores ranging from 0 to 36 with scores over the cutoff point of 12 indicative of cases. [10] The psoriasis disability index (PDI) is a 15-item scale that specifically addresses self-reported disability in five areas life affected by psoriasis, viz., daily activities, employment, personal relationships, leisure time, and treatment effects over the past 4 weeks. [11] Each question is scored on a 4-point Likert scale ranging from as "not at all" (score 0) to "very much" (score 3). Disability is calculated by summing the score of each of the 15 questions with higher scores indicating greater disability. It is one of the most widely used tools to assess the disability and QoL in psoriasis.
The study design and protocol were approved by the Institutional Ethics Committee. Written informed consent was obtained from all patients. Data analysis was performed using MINITAB 17 statistical software. [12] rEsults Thirty-nine psoriasis patients participated in the study. The mean age of the sample was 41.77 years (standard deviation [SD] 13.15) with 51.3% (n = 20) males. The majority were Hindu by religion (79.5%), Nepali by ethnicity (69.2%), married (74.4%), and lived in a nuclear family (64.1%). Psoriasis vulgaris (n = 28) was the most common variant followed by palmoplantar (n = 9) and scalp psoriasis in two patients. Table 1 shows the distribution of severity, life stress, stigmatization, psychological morbidity, and disability experienced by patients with psoriasis.
Fifty-nine percent of the sample consisted of high-stress reactors (PLSI scores >10), i.e., they reacted significantly to the stress associated with a life of psoriasis. 58.9% (n = 23) of subjects had psychological morbidity (GHQ-12 scores >12). Scores on the domain of the PDI were as follows: daily activities (mean 3.62, SD 3.24), employment (mean 1.46, SD 2.01), personal relationships (mean 0.26, SD 0.67), leisure time (mean 1.51, SD 2.44), and treatment effects (mean 0.36, SD 0.74).
Multiple regression analysis was performed to assess the relative impact of clinical severity, stress, stigmatization, and psychological morbidity on psoriasis QoL [ Table 2 ]. The results of the regression indicated that four predictor variables (clinical severity of psoriasis, stress, stigma, and psychological morbidity) explained 61.05% of the variance (R-sq [adj] 56.46%, F = 13.32, P = 0.000) in QoL (response variable). Among the clinical and psychosocial variables, only psychological morbidity significantly predicted QoL (β = 0.310, t = 2.04, P < 0.049).
discussion
The interplay of psychosocial factors in determining the outcome, disability, and QoL in psoriasis has been an important area of research in psychodermatology. While most early research had focused on exploring the psychological morbidity in psoriasis, it has neglected QoL issues. Later studies, while having measured QoL, failed to include a multitude of factors such as life stress and stigma that influence QoL in psoriasis. The present study was an attempt to understand the QoL in psoriasis and explore its determinants in the physical, psychological, and social realms.
The clinical severity of psoriasis is an important factor influencing anxiety, social isolation, and poor QoL. [3] In the present study, the sample consisted of patients with milder forms of psoriasis (SPI-s score mean 5.32, SD 8.25). 59% of our sample consisted of high-stress reactors, despite most having a mild severity of psoriasis (SPI-s score mean 5.32, SD 8.25). This underscores the importance of delinking assumptions of a linear relationship between clinical severity and stress experienced. Moreover, a recent study from South India has observed that stress experienced by patients is not proportional to clinical severity. [13] Levels of stigmatization experienced by our sample were comparable to those reported by others. [14] Two-thirds of our sample suffered from psychological distress, which stresses the importance of this variable in predicting QoL in psoriasis. [15, 16] The domains of disability most affected by psoriasis were daily activities, followed by leisure time activities, employment treatment, and personal relationships in that order. The scores of the PDI (mean 7.26, SD 7.44) indicate an overall lower disability or higher QoL in our sample. This could be a reflection of lesser severity of illness, lower psychological morbidity, or lower levels of stigmatization, or a combination of all three factors. Manjula et al., in their study on QoL in psoriasis in a tertiary care teaching hospital in Kerala, reported a median score of 14.5, [17] and Rakhesh et al. similarly reported a higher mean PDI score of 17.06. [18] Despite these differences, the affected domains in both studies were identical to the present study, i.e., the areas most affected were daily activities and employment while the least affected was relationship.
Multiple regression analysis showed that these clinical and psychosocial variables explained 60.74% of the variance in QoL. In other words, approximately 60% of psoriasis QoL can be predicted by knowing the clinical severity of illness, stress, stigma, and psychological morbidity.
Among these biopsychosocial predictor variables, however, only psychological morbidity significantly predicted QoL (β = 0.314, t = 2.05, P < 0.049).
Three Indian studies have attempted to study QoL in psoriasis. Manjula et al., in a study on QoL in psoriasis (n = 32), reported correlations with age and gender on QoL. Since the study did not include any clinical or psychosocial variables, we could not draw any support from the study. [17] A study by Rakhesh et al. found significant correlations between psoriasis stress (PLSI), severity (PASI), and QoL (PDI). However, the authors did not attempt to perform a multiple regression analysis to assess the simultaneous impact of the variables on QoL. [18] Singh et al. also reported significant correlations between stress, QoL, and severity in psoriasis. However, stigma and psychological morbidity were not assessed. [19] Thus, our study has validated the findings of previous research wherein individual psychosocial factors, viz., stress and stigma, and psychological factors, have been shown to significantly correlate with QoL in psoriasis. Moreover, using regression analysis, we were able to quantify the relative impact of these variables on QoL. By finding psychological morbidity as the single most significant contributor and predictor of QoL, we have reiterated the importance of psychological factors in dermatology. The study is limited in its cross-sectional design where correlation does not necessarily imply causation. The small sample size also limits the power of the study.
conclusion
The uniqueness of our study lies in the fact that we holistically included all relevant biopsychosocial factors that impacted the QoL in psoriasis. The importance of psychosocial factors, especially psychological morbidity, in determining QoL is underscored.
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